Author
Listed:
- John Kee
(Department of Genetics at the Perelman School of Medicine at the University of Pennsylvania
Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania)
- Samuel Thudium
(Department of Genetics at the Perelman School of Medicine at the University of Pennsylvania
Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania)
- David M. Renner
(Department of Microbiology at the Perelman School of Medicine at the University of Pennsylvania
Penn Center for Research on Coronaviruses and Other Emerging Pathogens at the Perelman School of Medicine at the University of Pennsylvania)
- Karl Glastad
(Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania
Department of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania)
- Katherine Palozola
(Department of Genetics at the Perelman School of Medicine at the University of Pennsylvania
Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania)
- Zhen Zhang
(Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania
Department of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania)
- Yize Li
(Department of Microbiology at the Perelman School of Medicine at the University of Pennsylvania
Penn Center for Research on Coronaviruses and Other Emerging Pathogens at the Perelman School of Medicine at the University of Pennsylvania)
- Yemin Lan
(Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania)
- Joseph Cesare
(Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania
Department of Biochemistry and Biophysics at the Perelman School of Medicine at the University of Pennsylvania)
- Andrey Poleshko
(Department of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania)
- Anna A. Kiseleva
(Department of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania
Penn Cardiovascular Institute at the Perelman School of Medicine at the University of Pennsylvania
Institute for Regenerative Medicine at the Perelman School of Medicine at the University of Pennsylvania)
- Rachel Truitt
(Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania)
- Fabian L. Cardenas-Diaz
(Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania
Penn-CHOP Lung Biology Institute at the Perelman School of Medicine at the University of Pennsylvania)
- Xianwen Zhang
(University of Texas Medical Branch)
- Xuping Xie
(University of Texas Medical Branch)
- Darrell N. Kotton
(Boston University and Boston Medical Center
Boston University School of Medicine)
- Konstantinos D. Alysandratos
(Boston University and Boston Medical Center
Boston University School of Medicine)
- Jonathan A. Epstein
(Department of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania
Penn Cardiovascular Institute at the Perelman School of Medicine at the University of Pennsylvania
Institute for Regenerative Medicine at the Perelman School of Medicine at the University of Pennsylvania
Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania)
- Pei-Yong Shi
(University of Texas Medical Branch)
- Wenli Yang
(Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania)
- Edward Morrisey
(Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania
Penn-CHOP Lung Biology Institute at the Perelman School of Medicine at the University of Pennsylvania)
- Benjamin A. Garcia
(Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania
Department of Biochemistry and Biophysics at the Perelman School of Medicine at the University of Pennsylvania)
- Shelley L. Berger
(Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania
Department of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania
Department of Biology at the Perelman School of Medicine at the University of Pennsylvania)
- Susan R. Weiss
(Department of Microbiology at the Perelman School of Medicine at the University of Pennsylvania
Penn Center for Research on Coronaviruses and Other Emerging Pathogens at the Perelman School of Medicine at the University of Pennsylvania)
- Erica Korb
(Department of Genetics at the Perelman School of Medicine at the University of Pennsylvania
Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania)
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of 2019 and caused the devastating global pandemic of coronavirus disease 2019 (COVID-19), in part because of its ability to effectively suppress host cell responses1–3. In rare cases, viral proteins dampen antiviral responses by mimicking critical regions of human histone proteins4–8, particularly those containing post-translational modifications required for transcriptional regulation9–11. Recent work has demonstrated that SARS-CoV-2 markedly disrupts host cell epigenetic regulation12–14. However, how SARS-CoV-2 controls the host cell epigenome and whether it uses histone mimicry to do so remain unclear. Here we show that the SARS-CoV-2 protein encoded by ORF8 (ORF8) functions as a histone mimic of the ARKS motifs in histone H3 to disrupt host cell epigenetic regulation. ORF8 is associated with chromatin, disrupts regulation of critical histone post-translational modifications and promotes chromatin compaction. Deletion of either the ORF8 gene or the histone mimic site attenuates the ability of SARS-CoV-2 to disrupt host cell chromatin, affects the transcriptional response to infection and attenuates viral genome copy number. These findings demonstrate a new function of ORF8 and a mechanism through which SARS-CoV-2 disrupts host cell epigenetic regulation. Further, this work provides a molecular basis for the finding that SARS-CoV-2 lacking ORF8 is associated with decreased severity of COVID-19.
Suggested Citation
John Kee & Samuel Thudium & David M. Renner & Karl Glastad & Katherine Palozola & Zhen Zhang & Yize Li & Yemin Lan & Joseph Cesare & Andrey Poleshko & Anna A. Kiseleva & Rachel Truitt & Fabian L. Card, 2022.
"SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry,"
Nature, Nature, vol. 610(7931), pages 381-388, October.
Handle:
RePEc:nat:nature:v:610:y:2022:i:7931:d:10.1038_s41586-022-05282-z
DOI: 10.1038/s41586-022-05282-z
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Cassia Wagner & Kathryn E. Kistler & Garrett A. Perchetti & Noah Baker & Lauren A. Frisbie & Laura Marcela Torres & Frank Aragona & Cory Yun & Marlin Figgins & Alexander L. Greninger & Alex Cox & Hann, 2024.
"Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution,"
Nature Communications, Nature, vol. 15(1), pages 1-12, December.
- Andrea M. Chiariello & Alex Abraham & Simona Bianco & Andrea Esposito & Andrea Fontana & Francesca Vercellone & Mattia Conte & Mario Nicodemi, 2024.
"Multiscale modelling of chromatin 4D organization in SARS-CoV-2 infected cells,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
- Francisco S. Mesquita & Laurence Abrami & Lucie Bracq & Nattawadee Panyain & Vincent Mercier & Béatrice Kunz & Audrey Chuat & Joana Carlevaro-Fita & Didier Trono & F. Gisou van der Goot, 2023.
"SARS-CoV-2 hijacks a cell damage response, which induces transcription of a more efficient Spike S-acyltransferase,"
Nature Communications, Nature, vol. 14(1), pages 1-17, December.
- Bruno A. Rodriguez-Rodriguez & Grace O. Ciabattoni & Ralf Duerr & Ana M. Valero-Jimenez & Stephen T. Yeung & Keaton M. Crosse & Austin R. Schinlever & Lucie Bernard-Raichon & Joaquin Rodriguez Galvan , 2023.
"A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8,"
Nature Communications, Nature, vol. 14(1), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:610:y:2022:i:7931:d:10.1038_s41586-022-05282-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.